3-hydroxy-3-methylglutaryl-CoA lyase deficiency

Revision as of 18:59, 8 August 2012 by WikiBot (talk | contribs) (Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
3-hydroxy-3-methylglutaryl-CoA lyase deficiency
Error creating thumbnail: File missing
HMG-CoA
OMIM 246450
DiseasesDB 29826
MeSH C008047

WikiDoc Resources for 3-hydroxy-3-methylglutaryl-CoA lyase deficiency

Articles

Most recent articles on 3-hydroxy-3-methylglutaryl-CoA lyase deficiency

Most cited articles on 3-hydroxy-3-methylglutaryl-CoA lyase deficiency

Review articles on 3-hydroxy-3-methylglutaryl-CoA lyase deficiency

Articles on 3-hydroxy-3-methylglutaryl-CoA lyase deficiency in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on 3-hydroxy-3-methylglutaryl-CoA lyase deficiency

Images of 3-hydroxy-3-methylglutaryl-CoA lyase deficiency

Photos of 3-hydroxy-3-methylglutaryl-CoA lyase deficiency

Podcasts & MP3s on 3-hydroxy-3-methylglutaryl-CoA lyase deficiency

Videos on 3-hydroxy-3-methylglutaryl-CoA lyase deficiency

Evidence Based Medicine

Cochrane Collaboration on 3-hydroxy-3-methylglutaryl-CoA lyase deficiency

Bandolier on 3-hydroxy-3-methylglutaryl-CoA lyase deficiency

TRIP on 3-hydroxy-3-methylglutaryl-CoA lyase deficiency

Clinical Trials

Ongoing Trials on 3-hydroxy-3-methylglutaryl-CoA lyase deficiency at Clinical Trials.gov

Trial results on 3-hydroxy-3-methylglutaryl-CoA lyase deficiency

Clinical Trials on 3-hydroxy-3-methylglutaryl-CoA lyase deficiency at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on 3-hydroxy-3-methylglutaryl-CoA lyase deficiency

NICE Guidance on 3-hydroxy-3-methylglutaryl-CoA lyase deficiency

NHS PRODIGY Guidance

FDA on 3-hydroxy-3-methylglutaryl-CoA lyase deficiency

CDC on 3-hydroxy-3-methylglutaryl-CoA lyase deficiency

Books

Books on 3-hydroxy-3-methylglutaryl-CoA lyase deficiency

News

3-hydroxy-3-methylglutaryl-CoA lyase deficiency in the news

Be alerted to news on 3-hydroxy-3-methylglutaryl-CoA lyase deficiency

News trends on 3-hydroxy-3-methylglutaryl-CoA lyase deficiency

Commentary

Blogs on 3-hydroxy-3-methylglutaryl-CoA lyase deficiency

Definitions

Definitions of 3-hydroxy-3-methylglutaryl-CoA lyase deficiency

Patient Resources / Community

Patient resources on 3-hydroxy-3-methylglutaryl-CoA lyase deficiency

Discussion groups on 3-hydroxy-3-methylglutaryl-CoA lyase deficiency

Patient Handouts on 3-hydroxy-3-methylglutaryl-CoA lyase deficiency

Directions to Hospitals Treating 3-hydroxy-3-methylglutaryl-CoA lyase deficiency

Risk calculators and risk factors for 3-hydroxy-3-methylglutaryl-CoA lyase deficiency

Healthcare Provider Resources

Symptoms of 3-hydroxy-3-methylglutaryl-CoA lyase deficiency

Causes & Risk Factors for 3-hydroxy-3-methylglutaryl-CoA lyase deficiency

Diagnostic studies for 3-hydroxy-3-methylglutaryl-CoA lyase deficiency

Treatment of 3-hydroxy-3-methylglutaryl-CoA lyase deficiency

Continuing Medical Education (CME)

CME Programs on 3-hydroxy-3-methylglutaryl-CoA lyase deficiency

International

3-hydroxy-3-methylglutaryl-CoA lyase deficiency en Espanol

3-hydroxy-3-methylglutaryl-CoA lyase deficiency en Francais

Business

3-hydroxy-3-methylglutaryl-CoA lyase deficiency in the Marketplace

Patents on 3-hydroxy-3-methylglutaryl-CoA lyase deficiency

Experimental / Informatics

List of terms related to 3-hydroxy-3-methylglutaryl-CoA lyase deficiency


3-hydroxy-3-methylglutaryl-CoA lyase deficiency also referred to as HMG-CoA lyase deficiency or Hydroxymethylglutaric aciduria, is an uncommon inherited disorder in which the body cannot properly process the amino acid leucine. Additionally, the disorder prevents the body from making ketones, which are used for energy during fasting.

Presentation

This disorder usually appears within the first year of life. The signs and symptoms of HMG-CoA lyase deficiency include vomiting, dehydration, lethargy, convulsions, and coma. When episodes occur in an infant or child, blood sugar becomes extremely low (hypoglycemia), and harmful compounds can build up and cause the blood to become too acidic (metabolic acidosis). These episodes are often triggered by an infection, fasting, strenuous exercise, or sometimes other types of stress.

Differential diagnosis

This condition is sometimes mistaken for Reye syndrome, a severe disorder that develops in children while they appear to be recovering from viral infections such as chicken pox or flu. Most cases of Reye syndrome are associated with the use of aspirin during these viral infections.

Cause

Mutations in the HMGCL gene cause 3-hydroxy-3-methylglutaryl-CoA lyase deficiency. The enzyme made by the HMGCL gene plays an essential role in breaking down dietary proteins and fats for energy. Specifically, the enzyme is responsible for processing leucine, an amino acid that is part of many proteins. This enzyme also produces ketones during the breakdown of fats. If a mutation in the HMGCL gene reduces or eliminates the activity of this enzyme, the body is unable to process leucine or make ketones properly. A lack of ketones leads to hypoglycemia, and compounds called organic acids (which are formed as products of amino acid and fat breakdown) can cause the blood to become too acidic. Metabolic acidosis and hypoglycemia impair tissue function, especially in the central nervous system.

Incidence

This is a rare condition that has been reported in fewer than 100 individuals throughout the world. This condition is inherited in an autosomal recessive pattern.

See also

References

This article incorporates public domain text from The U.S. National Library of Medicine

External links

Template:WikiDoc Sources